LIA
TEVA icon

LS Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

LS Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,800
Closed -$35K – 1387
2020
Q2 		$35K Sell
2,800
-1,153
-29% -$13K ﹤0.01% 1257
2020
Q1 		$35K Sell
3,953
-6,864
-63% -$70.3K ﹤0.01% 1205
2019
Q4 		$106K Hold
10,817
– – 0.01% 1095
2019
Q3 		$74K Buy
10,817
+2,628
+32% +$20.1K ﹤0.01% 1169
2019
Q2 		$76K Hold
8,189
– – ﹤0.01% 1175
2019
Q1 		$128K Hold
8,189
– – 0.01% 984
2018
Q4 		$126K Sell
8,189
-460
-5% -$9.43K 0.01% 948
2018
Q3 		$186K Sell
8,649
-2,247
-21% -$52.2K 0.01% 885
2018
Q2 		$265K Hold
10,896
– – 0.02% 751
2018
Q1 		$186K Hold
10,896
– – 0.01% 886
2017
Q4 		$206K Sell
10,896
-100
-0.9% -$1.5K 0.01% 878
2017
Q3 		$194K Hold
10,996
– – 0.01% 936
2017
Q2 		$365K Buy
10,996
+7,736
+237% +$239K 0.02% 649
2017
Q1 		$105K Hold
3,260
– – 0.01% 1101
2016
Q4 		$118K Hold
3,260
– – 0.01% 990
2016
Q3 		$150K Hold
3,260
– – 0.01% 888
2016
Q2 		$164K Buy
3,260
+2,515
+338% +$134K 0.01% 838
2016
Q1 		$40K Sell
745
-97
-12% -$5.69K ﹤0.01% 1257
2015
Q4 		$55K Hold
842
– – ﹤0.01% 1114
2015
Q3 		$48K Hold
842
– – ﹤0.01% 1159
2015
Q2 		$50K Hold
842
– – ﹤0.01% 1171
2015
Q1 		$52K Hold
842
– – ﹤0.01% 695
2014
Q4 		$48K Hold
842
– – ﹤0.01% 706
2014
Q3 		$45K Hold
842
– – ﹤0.01% 705
2014
Q2 		$44K Buy
842
+182
+28% +$9.3K ﹤0.01% 705
2014
Q1 		$35K Hold
660
– – ﹤0.01% 710
2013
Q4 		$26K Sell
660
-200
-23% -$7.88K ﹤0.01% 753
2013
Q3 		$32K Hold
860
– – ﹤0.01% 596
2013
Q2 		$34K Buy
+860
New +$33.5K ﹤0.01% 401

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

LS Investment Advisors's TEVA Position: Q3 2020 in Review

LS Investment Advisors sold out of Teva Pharmaceuticals (TEVA) in Q3 2020, closing a stake of 2,800 shares — an estimated $35K sold.

LS Investment Advisors first reported a position in TEVA in Q2 2013 and held it in 29 quarters. The position peaked at $365K in Q2 2017. 443 funds tracked by Wall St. Rank hold TEVA as of Q3 2020.

  • LS Investment Advisors reported no remaining Teva Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • LS Investment Advisors sold 2,800 Teva Pharmaceuticals shares in Q3 2020, an estimated $35K.
  • LS Investment Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 29 quarters.
  • LS Investment Advisors's Teva Pharmaceuticals position peaked at $365K in Q2 2017.
  • 443 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2020.

Based on LS Investment Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.